Graves' Disease Market Research Reports & Industry Analysis
Graves' Disease Industry Research & Market Reports
-
Carbimazole Market by Indication (Graves' Disease, Toxic Multinodular Goiter), End users (Clinics, Hospitals), Distribution Channel - Global Forecast 2024-2030
... USD 245.90 million in 2024, at a CAGR 4.81% to reach USD 326.59 million by 2030. The carbimazole is a medical compound primarily utilized for treating hyperthyroidism, a condition where the thyroid gland produces excessive ... Read More
-
Graves' Disease – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Graves' Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Graves' Disease market report provides current treatment practices, emerging drugs, Graves' ... Read More
-
Graves Orbitopathy – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Graves Orbitopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Graves Orbitopathy market report provides current treatment practices, emerging drugs, Graves ... Read More
-
Graves' Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... comprehensively analyzed in IMARC's new report titled "Graves' Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Graves' disease is an autoimmune illness that affects the thyroid gland and causes an overproduction ... Read More
-
Graves' Disease Market Size, Trends, Analysis, and Outlook By Diagnosis (Ultrasound, Imaging Test, Radioactive Iodine Uptake, Blood Sample), By Treatment (Anti-Thyroid Medication, Radioactive Iodine Therapy, Surgery), by Country, Segment, and Companies, 2024-2032
... Disease market size is poised to register 4.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Graves' Disease market across By Diagnosis ... Read More
-
Thyroid Eye Disease Treatment Market Size, Trends, Analysis, and Outlook By Treatment (Monoclonal Antibody, Steroids, Artificial Tear Drops, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce), by Country, Segment, and Companies, 2024-2032
... Thyroid Eye Disease Treatment market size is poised to register 8.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Thyroid Eye Disease ... Read More
-
The 2025-2030 World Outlook for Thyroid Gland Disorders
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Graves’ Disease- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Graves’ ... Read More
-
Graves' Disease
... includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • ... Read More
-
Graves Ophthalmopathy - Epidemiology Forecast - 2032
... with lesser degrees of Graves’ Ophthalmopathy can be challenging, and this may be the primary cause for low diagnosis rate seen across the 7MM since many people go misdiagnosed. Graves’ Ophthalmopathy is a potentially sight-threatening ... Read More
-
Graves Disease Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... the COVID-19 pandemic hurt the world economy and the healthcare system. There is a need to streamline the healthcare process during the COVID-19 times. Due to the COVID-19-led outages, there was the temporary shutdown of ... Read More
-
Graves' Ophthalmopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves' Ophthalmopathy - Drugs In Development, 2022, provides an overview of the Graves' Ophthalmopathy (Ophthalmology) pipeline landscape. Graves’ ophthalmopathy is an autoimmune condition where the ... Read More
-
Graves Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Graves Diseases (Hormonal Disorders) pipeline landscape. Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Symptoms include anxiety, weight loss, change in menstrual ... Read More
-
Graves Disease Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... the COVID-19 pandemic hurt the world economy and the healthcare system. There is a need to streamline the healthcare process during the COVID-19 times. Due to the COVID-19-led outages, there was the temporary shutdown of ... Read More
-
Graves’ Disease- Pipeline Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More
-
Graves’ Orbitopathy- Pipeline Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Graves’ ... Read More
-
Graves Ophthalmopathy - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Graves Ophthalmopathy market report provides current treatment practices, emerging drugs, Graves Ophthalmopathy market share of the individual therapies, current and forecasted Graves Ophthalmopathy ... Read More
-
Graves Orbitopathy - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Graves Orbitopathy Understanding The DelveInsight Graves Orbitopathy ... Read More
-
Graves Disease - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Graves Disease Understanding The DelveInsight Graves Disease ... Read More
-
Graves Ophthalmopathy - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Graves Ophthalmopathy Understanding The DelveInsight Graves Ophthalmopathy ... Read More
Research Assistance
